1991
DOI: 10.1016/0223-5234(91)90150-l
|View full text |Cite
|
Sign up to set email alerts
|

Sulfide and phosphine ligands in carboplatin analogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1992
1992
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Ligand structural compositions beyond am(m)ines, specifically Pt-phosphine or mixed phosphine/am(m)ine complexes, also show considerable antitumor activity. Complexes with open or exchangeable coordination positions appear to operate in the more classic cisplain-like manner via DNA adduct formation, ,,,,, while coordinatively saturated structures, especially those with chelating lipophilic phosphines, are proposed to function by a unique anti-mitochondrial mechanism. ,, This functional divergence may be the reason that these cationic complexes are active against cisplatin-resistant cells.…”
Section: Introductionmentioning
confidence: 99%
“…Ligand structural compositions beyond am(m)ines, specifically Pt-phosphine or mixed phosphine/am(m)ine complexes, also show considerable antitumor activity. Complexes with open or exchangeable coordination positions appear to operate in the more classic cisplain-like manner via DNA adduct formation, ,,,,, while coordinatively saturated structures, especially those with chelating lipophilic phosphines, are proposed to function by a unique anti-mitochondrial mechanism. ,, This functional divergence may be the reason that these cationic complexes are active against cisplatin-resistant cells.…”
Section: Introductionmentioning
confidence: 99%
“…It can detect mutagens at a much lower concentration than the E. coli and Salmonella mutation assays, owing to the high permeability of chemicals through the cell membrane of B. subtilis (Yamaguchi, 1989). Cisplatin (Sampedro et al, 1991;Khokhar et al, 1993), which is widely used as a cancer chemotherapeutic drug causing DNA damage, was chosen as a standard drug for comparing the activity with the tested compounds.…”
Section: Resultsmentioning
confidence: 99%
“…It has been supposed that the distribution and the concentration of platinum-based drugs in different body districts are influenced by physicochemical properties of the ligands such as polarity, hydrophilicity, and steric requirements [3]. Among several other modifications, the possibility of structurally modifying cisplatin by introducing phosphines as neutral ligands has been considered [4,5].…”
Section: Introductionmentioning
confidence: 99%